1. [Cefotetan treatment of suppurative bronchopulmonary syndromes sustained by anaerobic germs].
- Author
-
Caputi M, Guarino C, Cautiero V, Sorrentino L, Cione P, Cuccurullo S, and Tarantino C
- Subjects
- Adolescent, Adult, Aged, Bacterial Infections microbiology, Bacteriological Techniques instrumentation, Bronchiectasis microbiology, Cefotetan pharmacology, Child, Female, Humans, Lung Abscess microbiology, Male, Microbial Sensitivity Tests, Middle Aged, Respiratory Tract Infections microbiology, Bacteria, Anaerobic drug effects, Bacteria, Anaerobic isolation & purification, Bacterial Infections drug therapy, Bronchiectasis drug therapy, Cefotetan therapeutic use, Lung Abscess drug therapy, Respiratory Tract Infections drug therapy
- Abstract
The Authors have analyzed the effect of Cefotetan in 20 patients affected by bronchopulmonary pathologies supported by anaerobic bacterium. During 7 days doses of 50 mg. pro Kg/pro die were given. From beginning to end of the treatment clinical, hematochemical and radiological data were evaluated. Bacteriological analysis was made on samples drawn with BFS according to a traditional method and with microbiology specimen brush. Almost all the patients (95%) realized improvements in clinical symptomatology and in radiological picture.
- Published
- 1990